Latest Advances

  • Condition: Pulmonary Metastases in Pseudomyxoma Peritonei
  • Journal: Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti
  • Treatment Used: Cytoreductive Surgeries
  • Number of Patients: 1
  • Published —
This article reviewed the case of a patients with pulmonary metastases (cancer that starts in one part of the body and spreads to the lungs) in pseudomyxoma peritonei (slow growing cancer that usually starts in the appendix) treated with cytoreductive surgery (aims to reduce the number of cancer cells by removing the primary tumor).
  • Condition: Pseudomyxoma Peritonei (PMP)
  • Journal: Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti
  • Treatment Used: Surgery
  • Number of Patients: 73
  • Published —
This study evaluated patients with pseudomyxoma peritonei (appendix cancer) undergoing surgery.
  • Condition: Pseudomyxoma Peritonei
  • Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • Treatment Used: Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy
  • Number of Patients: 254
  • Published —
In this study, researchers evaluated the safety of undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for the treatment of pseudomyxoma peritonei. 
  • Condition: Bulky Pseudomyxoma Peritonei
  • Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
  • Treatment Used: Two-Stage Cytoreductive Surgery
  • Number of Patients: 8
  • Published —
This study tested the safety and efficacy of using two-stage cytoreductive surgery to treat patients with bulky pseudomyxoma peritonei infections.
  • Condition: Hodgkin's Lymphoma
  • Journal: Journal of cancer research and therapeutics
  • Treatment Used: Combined Modality Treatment
  • Number of Patients: 125
  • Published —
In this study, researchers evaluated the outcomes of using combined modality treatment for Hodgkin's lymphoma.
  • Condition: Primary and Metastatic Peritoneal tumors in Covid-19 Pandemic
  • Journal: Journal de chirurgie viscerale
  • Treatment Used: Prioritization of Hyperthermic Intraoperative Peritoneal Chemotherapy (HIPEC) and Cytoreduction Surgery
  • Number of Patients: 0
  • Published —
This article discusses treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic.
  • Condition: Pseudomyxoma Peritonei
  • Journal: International journal of clinical oncology
  • Treatment Used: Modified FOLFOX6 Chemotherapy
  • Number of Patients: 8
  • Published —
In this study, researchers evaluated the outcomes of using modified FOLFOX6 chemotherapy for the treatment of pseudomyxoma peritonei.
  • Condition: Peritoneal Carcinomatosis of Gastric Origin
  • Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
  • Treatment Used: Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Number of Patients: 0
  • Published —
This article summarized the contemporary role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of gastric cancer.
  • Condition: Pseudomyxoma Peritonei (PMP)
  • Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • Treatment Used: Cytoreduction Surgery (CRS) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Number of Patients: 65
  • Published —
This study analyzed the effectiveness and safety of cytoreduction surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei (cancer of the appendix; PMP) in the early stage.
  • Condition: Peritoneal surface malignancies
  • Journal: Langenbeck's archives of surgery
  • Treatment Used: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
  • Number of Patients: 384
  • Published —
The study researched cytoreductive surgery (surgery to remove tumors) and hyperthermic intraperitoneal chemotherapy (filling the abdominal area with heated chemotherapy) for peritoneal surface malignancies.
  • Condition: Extensive pseudomyxoma peritonei
  • Journal: Surgical oncology
  • Treatment Used: Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
  • Number of Patients: 245
  • Published —
The study researched the effects of complete cytoreductive surgery (surgery to remove cancer cells) and hyperthermic intraperitoneal chemotherapy (flushing heated chemotherapy through the chest cavity during surgery) on extensive pseudomyxoma peritonei.
  • Condition: Pseudomyxoma Peritonei (PMP) Originating from Appendiceal Neoplasms
  • Journal: BJS open
  • Treatment Used: Cytoreductive Surgery and Hyper-Thermic Intraperitoneal Chemotherapy (CRC-HIPEC)
  • Number of Patients: 225
  • Published —
This study identified prognostic factors for recurrence and survival after cytoreductive surgery and hyper-thermic intraperitoneal chemotherapy (CRS-HIPEC) for the treatment of patients with pseudomyxoma peritonei (mucin in peritoneal cavity; PMP).
Showing 1-12 of 20